Financhill
Back

Innovate Vs. United Therapeutics Industry Stock Comparison

Sell
34

VATE
Innovate

Last Price:
$5.71
Seasonality Move:
-13.9%
Sell
47

UTHR
United Therapeutics

Last Price:
$300.65
Seasonality Move:
7.07%
Sell
34
Innovate (VATE) is a Sell

Is Innovate a Buy, Sell or Hold?

  • The current Innovate [VATE] share price is $5.68. The Score for VATE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • VATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
United Therapeutics (UTHR) is a Sell

Is United Therapeutics a Buy, Sell or Hold?

  • The current United Therapeutics [UTHR] share price is $300.56. The Score for UTHR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • UTHR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VATE Stock Price Chart

What is Innovate's stock price today?

  • The Innovate share price today is $5.68
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VATE is experiencing buying pressure, which is a positive indicator for future bullish movement.

UTHR Stock Price Chart

What is United Therapeutics's stock price today?

  • The United Therapeutics share price today is $300.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.

VATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.79 Buy
Relative Strength Index (14 RSI): 52.69 Buy
Chaikin Money Flow: 15320 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.24 - 5.62) Buy
Bollinger Bands (100): (5.07 - 9.03) Sell

UTHR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 42.11 Buy
Relative Strength Index (14 RSI): 54.54 Buy
Chaikin Money Flow: 364427 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (280.44 - 310.86) Buy
Bollinger Bands (100): (285.27 - 330.57) Sell

VATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.41 Buy
20-day SMA: 5.37 Buy
50-day SMA: 5.89 Sell
200-day SMA: 6.52 Sell
8-day EMA: 2.21 Buy
20-day EMA: 1.01 Buy
50-day EMA: 0.43 Buy
200-day EMA: 0.11 Buy

UTHR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 292.2 Buy
20-day SMA: 288.46 Buy
50-day SMA: 301.09 Sell
200-day SMA: 336.07 Sell
8-day EMA: 117.68 Buy
20-day EMA: 53.99 Buy
50-day EMA: 22.88 Buy
200-day EMA: 5.89 Buy

Innovate Earnings Growth & VATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

United Therapeutics Earnings Growth & UTHR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.88 per share, an increase next quarter of $0.66 per share, an increase this year of $2.59 per share, and an increase next year of $0.97 per share.

Innovate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):